skip navigation Smaller text size Reset text size Larger text size
Families & Children Women Teens Adults Seniors People with Disabilities
DHHS Home > Office of Medicaid & Business Policy >
Clinical Prior Authorization

medicationsThe Clinical Prior Authorization (PA) Program was implemented to improve quality and manage drug classes that have been identified as requiring additional monitoring. This program is also intended as a means of ensuring that drugs are being prescribed for the right patients and for the appropriate reasons, while still monitoring drug expenditures.

 

Clinical Prior Authorization

Allergen Extract Medications Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Anti-Obesity Medication Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Asthma/Allergy Immunomodulators Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Benign Prostatic Hyperplasia (BPH) Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Bowel Disorders Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Brand Name Drug Approval Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
CNS Stimulant/ADHD Medication Approval Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Cymbalta® Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Direct Renin Inhibitor Medications Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Fibromyalgia Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Growth Hormone Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Hematopoietic Agents Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Hepatitis C Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Huntington's Disease Medications Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Hyaluronic Acid Derivatives Injection Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Hypercholesterolemia Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Inhaled Insulin Medications Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Legend Topical NSAIDS Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Long-Acting Narcotic Medications Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Lyrica® Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Methadone Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Onychomycosis Agents Approval Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Oral Isotretinoin Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Oral NSAIDS Legend Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Proprotein Convertase Subtilisin/Kexin
type 9 (PCSK9) Medications
Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Proton Pump Inhibitor Approval Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Receptor Selective NSAID Authorization Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Restless Leg Syndrome Medication Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Short Acting Fentanyl Analgesics Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Suboxone®/buprenorphine Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Symlin® Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Synagis Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Systemic Immunomodulators Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Topical Combination Acne Products Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
Topical Immunomodulators Request Form Adobe Acrobat Reader Symbol Criteria Adobe Acrobat Reader Symbol
  • How do I request a prior authorization?
    • Requests for prior authorization must be initiated by the prescriber and may be initiated via phone, fax or mail. The Magellan Medicaid Administration phone number is (866) 675-7755 and the fax number is (888) 603-7696.
  • How are the clinical criteria determined?
    • The Drug Use Review (DUR) Board recommends the specific clinical criteria. The DUR is composed of practicing pharmacists and physicians.
  • How often are the drugs and clinical criteria reviewed?
    • DHHS periodically reviews the drugs and the clinical criteria. Updates to the list of drugs and the clinical criteria are made in accordance with current clinical practices.
  • Who can I contact for more information?
    • For more information or assistance prescribers may call the Magellan Medicaid Administration Clinical Call Center at: (866)-675-7755.

Adobe Acrobat Reader Symbol Adobe Acrobat Reader format. You can download a free reader from Adobe.

 
Translate this page

Disclaimer

New Hampshire Department of Health and Human Services
129 Pleasant Street | Concord, NH | 03301-3852


copyright 2016. State of New Hampshire